Seguir
Ashwani Sood
Ashwani Sood
Professor, PGIMER, Chandigarh
Dirección de correo verificada de pgimer.edu.in
Título
Citado por
Citado por
Año
Head and Neck Imaging E-Book: Head and Neck Imaging E-Book
PM Som, HD Curtin
Elsevier Health Sciences, 2011
9302011
Comparative effectiveness of ultrasonography, 99mTc-sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism
NTK Thanseer, SK Bhadada, A Sood, BR Mittal, A Behera, AKR Gorla, ...
Clinical nuclear medicine 42 (12), e491-e497, 2017
1342017
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia
BA Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A
Clin Nucl Med 40 (1), e6-e10, 2015
1022015
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study
MM Sathekge, IO Lawal, C Bal, F Bruchertseifer, S Ballal, G Cardaci, ...
The lancet oncology 25 (2), 175-183, 2024
662024
Alternative Lymphatic Pathway Following Previous Axillary Node Dissection in Recurrent / Primary Breast Cancer
ADHM Sood A, Youssef IM, Heiba SI, El Zeftawy HM, Axelrod D, Seigel B, Mills C
Clin Nucl Med 29 (11), 698-702, 2004
622004
Thyroid scintigraphy in detecting dual thyroid ectopy: A review
KR Sood A, Sood V, Sharma DR, Seam RK
Eur J Nucl Med & Mol Imaging 35 (4), 843-6, 2008
61*2008
Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer—a systematic review and meta-analysis
S Satapathy, A Sood, CK Das, BR Mittal
Prostate Cancer and Prostatic Diseases 24 (3), 880-890, 2021
592021
The ectopic thyroid gland and the role of nuclear medicine techniques in its diagnosis and management.
KR Sood A
Hell J Nucl Med 11 (3), 168-171, 2008
442008
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial
S Satapathy, BR Mittal, A Sood, CK Das, RS Mavuduru, S Goyal, J Shukla, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-11, 2022
432022
Visceral metastases as predictors of response and survival outcomes in patients of castration-resistant prostate cancer treated with 177Lu-labeled prostate-specific membrane …
S Satapathy, BR Mittal, A Sood
Clinical Nuclear Medicine 45 (12), 935-942, 2020
422020
Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry
S Harikrishnan, A Bahl, A Roy, A Mishra, J Prajapati, CN Manjunath, ...
ESC Heart Failure 9 (6), 3898-3908, 2022
352022
Real-time intraprocedural 18F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior …
RK Radhakrishnan, BR Mittal, AKR Gorla, RK Basher, A Sood, A Bal, ...
The British Journal of Radiology 90 (1080), 20170258, 2017
352017
Epidemiological study of hypertension in young (15-24 yr) Delhi urban population.
N Gopinath, SL Chadha, AK Sood, S Shekhawat, SP Bindra, R Tandon
The Indian Journal of Medical Research 99, 32-37, 1994
341994
Tumor-induced osteomalacia: experience from three tertiary care centers in India
R Pal, SK Bhadada, A Singhare, A Bhansali, S Kamalanathan, M Chadha, ...
Endocrine Connections 8 (3), 266-276, 2019
332019
Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry
AK Arya, P Kumari, SK Bhadada, K Agrawal, P Singh, S Mukherjee, ...
Journal of bone and mineral metabolism 39, 253-259, 2021
322021
Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors
KJ Rodabaugh, P Mhawech-Fauceglia, J Groth, S Lele, AK Sood
International journal of gynecological pathology 26 (1), 10-15, 2007
322007
Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS
AS Parihar, A Sood, R Kumar, P Bhusari, J Shukla, BR Mittal
European Journal of Nuclear Medicine and Molecular Imaging 45, 1836-1837, 2018
312018
Health-related quality-of-life outcomes with actinium-225-prostate-specific membrane antigen-617 therapy in patients with heavily pretreated metastatic castration-resistant …
S Satapathy, BR Mittal, A Sood, CK Das, SK Singh, RS Mavuduru, ...
Indian Journal of Nuclear Medicine 35 (4), 299-304, 2020
302020
Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low-and middle-income countries: preliminary results from the IAEA PERTAIN trial
T Konert, WV Vogel, D Paez, A Polo, E Fidarova, H Carvalho, PS Duarte, ...
European Journal of Nuclear Medicine and Molecular Imaging 46, 2235-2243, 2019
272019
Frequency & predictors of pancreatitis in symptomatic primary hyperparathyroidism
AK Arya, SK Bhadada, S Mukherjee, P Singh, SS Rana, D Dahiya, ...
Indian Journal of Medical Research 148 (6), 721-727, 2018
272018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20